SCHEMBL4595417

SCHEMBL4595417

CC(=O)Oc1ccc(C)cc1C#N

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.48
ALDH1A1 P00352 3/20 0.46
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
LMNA P02545 2/20 0.44
S1PR1 P21453 1/20 0.42
TSHR P16473 3/20 0.42
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
AR P10275 3/20 0.42
IMPDH2 P12268 1/20 0.42
FFAR1 O14842 1/20 0.42
CFD P00746 1/20 0.41
XDH P47989 1/20 0.40
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3375489 0.90 MAOB (0.45) MAOBALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL9034189 0.86 AR (0.43) MAOBALDH1A1KDM4EARIMPDH2
SCHEMBL11464186 0.84 ALDH1A1 (0.47) MAOBALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL4595414 0.83 ALDH1A1 (0.43) MAOBALDH1A1RAB9ANPC1KDM4E
SCHEMBL4324072 0.81 ALDH1A1 (0.62) MAOBALDH1A1RAB9ALMNAS1PR1
SCHEMBL1667669 0.81 CFD (0.47) MAOBALDH1A1RAB9AS1PR1TSHR
SCHEMBL6175873 0.81 MAOB (0.47) MAOBALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL16421474 0.81 ALDH1A1 (0.50) MAOBALDH1A1RAB9ASMN1; SMN2TSHR
SCHEMBL13946931 0.79 MAOB (0.45) MAOBALDH1A1RAB9ASMN1; SMN2S1PR1
SCHEMBL8007448 0.78 RAB9A (0.49) MAOBALDH1A1RAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1945646-A1 PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS Cellzome (UK) Ltd. (GB) 2008-07-23 EP disclosed
WO-2007039467-A1 PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS CELLZOME (UK) LTD. (GB) 2007-04-12 WO disclosed